Fulminant type 1 diabetes mellitus in pregnancy

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Chun-Yu LiYu-Wei Zhang

Abstract

Fulminant type 1 diabetes mellitus (FT1DM) has received clinical attention for its low incidence and poor prognosis. Currently, few cases of FT1DM are associated with pregnancy in clinical practice, but it poses a great threat to the life of mothers and infants. Here, we present two cases of FT1DM in pregnancy. In Case 1, the patient was a 26-year-old woman who was admitted to the hospital with reduced fetal movement. She was diagnosed with FT1DM and delivered a dead female fetus. Lispro and lantus were administered to control blood glucose, and lipoic acid for antioxidant therapy. In Case 2, the patient was a 28-year-old woman who developed nausea, vomiting, diarrhea, and polydipsia, which later proved to be FT1DM. An abortion was induced and blood glucose levels were controlled using an insulin pump. All physicians should be aware of this disease in order to provide prompt diagnosis and emergency treatment, thus improving maternal prognosis. We suggest that plasma glucose/hemoglobin A1C ratio be adopted as a new clinical parameter in predicting FT1DM.

References

Jul 29, 2003·Diabetes Care·Akihisa ImagawaHideichi Makino
Nov 10, 2005·The Journal of Clinical Endocrinology and Metabolism·I ShimizuT Hanafusa
Jul 25, 2009·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·I TorresM Aguilar-Diosdado
Oct 9, 2009·Diabetologia·Y KawabataUNKNOWN Committee on Type 1 Diabetes, Japan Diabetes Society
Nov 10, 2011·Diabetes/metabolism Research and Reviews·Akihisa Imagawa, Toshiaki Hanafusa
Apr 26, 2013·The Journal of Medical Investigation : JMI·Masafumi KogaUNKNOWN Japan Diabetes Society's Committee Of Research On Type 1 Diabetes Mellitus
May 22, 2016·Diabetes Care·Boris Kovatchev, Claudio Cobelli
Oct 14, 2016·Internal Medicine Journal·M T FarrantT Cundy
May 6, 2019·Clinical and Experimental Pharmacology & Physiology·Lingwen YingJian Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.